Press Release Slate Medicines Announces First Participant Dosed in Phase 1 Study Evaluating SLTE-1009 2 hours ago
Press Release Slate Medicines Establishes Clinical and Scientific Advisory Boards to Advance Next-Generation Migraine Prevention Therapeutics Jul 28